pISSN 2636-0004
eISSN 2636-0012

Table. 2.

Tumor Characteristics, Tumor-Feeder Detectability, and Technical Success of TACE in Each Subsegment

Characteristic Spiegel lobe (n = 30) Paracaval portion (n = 38) Caudate process (n = 11)
Mean diameter (mm) (range) 16.8 ± 9.5 (6–48) 19.6 ± 9.7 (6–53) 21.8 ± 9.9 (9–36)
Origins of tumor-feeders R1, 6; R2, 3; L1, 3; L2, 5; A, 6; P, 3; M, 5; A2, 2; and Ex, 2 (the 3 o’clock artery and RGA) R1, 3; R2, 6; L1, 2; L2, 6; A, 27; P, 13; M, 11; A2, 1; A3, 1; and A8, 5 R1, 1; R2, 2; A, 5; P, 7; A7, 1; and A6, 1
No. of embolized artery 35 77 17
No. of embolized artery/per tumor 1.3 ± 0.9/tumor 2.0 ± 0.9/tumor 1.5 ± 0.9/tumor
Detectability of tumor-feeders (%) 71.4 94.8 76.5
Technical success of TACE (%)
Grade A 93.3 65.8 63.6
Grade B 0 21.1 18.2
Grade C 6.7 10.5 18.2
CR rate at 2–4 months* 93.1 59.4 80
Durable CR rate* 79.3 34.4 30

Values are presented as mean ± standard deviation or number only

RGA, right gastric artery; A2, the superior lateral subsegmental artery of the left hepatic artery; A3, the inferior lateral subsegmental artery of the left hepatic artery; A8, the anterior superior subsegmental artery of the right hepatic artery; A7, the posterior superior subsegmental artery of the right hepatic artery; A6, the posterior inferior subsegmental artery of the right hepatic artery; CR, complete response

*CR rates were evaluated in 29 tumors in the Spiegel lobe, 32 in the paracaval portion, and 10 in the caudate process

Int J Gastrointest Interv 2023;12:75~82 https://doi.org/10.18528/ijgii220029
© Int J Gastrointest Interv